PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Genetic Technologies Limited (GTG.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

AU000000GTG7

Sector

Healthcare

Highlights

Market Cap

A$5.67M

Total Revenue (TTM)

A$4.80M

Gross Profit (TTM)

A$2.80M

EBITDA (TTM)

-A$5.47M

Year Range

A$0.04 - A$0.19

Target Price

A$0.25

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Genetic Technologies Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%5.00%10.00%15.00%20.00%25.00%SeptemberOctoberNovemberDecember2025February0
16.45%
GTG.AX (Genetic Technologies Limited)
Benchmark (^GSPC)

Returns By Period

Genetic Technologies Limited had a return of 0.00% year-to-date (YTD) and -61.00% in the last 12 months. Over the past 10 years, Genetic Technologies Limited had an annualized return of -37.90%, while the S&P 500 had an annualized return of 11.21%, indicating that Genetic Technologies Limited did not perform as well as the benchmark.


GTG.AX

YTD

0.00%

1M

0.00%

6M

-4.88%

1Y

-61.00%

5Y*

-47.63%

10Y*

-37.90%

^GSPC (Benchmark)

YTD

2.90%

1M

3.70%

6M

10.94%

1Y

22.18%

5Y*

12.41%

10Y*

11.21%

*Annualized

Monthly Returns

The table below presents the monthly returns of GTG.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20250.00%0.00%
2024-18.52%9.09%16.67%-21.43%-9.09%-25.00%-44.00%-7.14%0.00%0.00%0.00%0.00%-71.11%
2023-16.67%60.00%-25.00%0.00%-16.67%0.00%0.00%-20.00%25.00%-20.00%25.00%-46.00%-55.00%
2022-20.00%0.00%25.00%-20.00%-25.00%0.00%33.33%0.00%0.00%-25.00%0.00%0.00%-40.00%
202133.33%0.00%-10.00%5.56%5.26%-15.00%-5.88%-6.25%-6.67%0.00%-14.29%-16.67%-33.33%
202081.82%-30.00%-28.57%-0.00%20.00%-16.67%100.00%0.00%-20.00%0.00%-12.50%7.14%36.36%
201933.34%0.00%0.00%-18.75%7.68%-14.28%-16.66%19.99%-16.66%7.14%0.00%10.00%-1.79%
201823.08%-12.50%-35.72%22.23%-9.10%0.00%10.01%-9.10%10.01%-0.00%-18.18%-33.33%-53.84%
2017-18.18%11.11%0.00%-10.00%-0.00%-22.23%-14.28%16.66%0.00%0.00%28.58%44.44%18.17%
2016-16.00%-9.53%0.00%5.27%10.00%-13.64%-5.26%-11.11%0.00%-18.75%38.47%-38.89%-56.00%
201566.66%112.00%-13.21%-17.39%13.16%-34.88%3.57%-27.59%-19.05%5.88%88.89%-26.47%66.66%
20145.45%1.73%-10.17%-3.77%-19.61%-12.20%-8.33%-18.18%-14.81%-21.74%-16.67%-0.00%-72.73%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of GTG.AX is 15, meaning it’s performing worse than 85% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of GTG.AX is 1515
Overall Rank
The Sharpe Ratio Rank of GTG.AX is 1313
Sharpe Ratio Rank
The Sortino Ratio Rank of GTG.AX is 1515
Sortino Ratio Rank
The Omega Ratio Rank of GTG.AX is 1313
Omega Ratio Rank
The Calmar Ratio Rank of GTG.AX is 1111
Calmar Ratio Rank
The Martin Ratio Rank of GTG.AX is 2323
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Genetic Technologies Limited (GTG.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for GTG.AX, currently valued at -0.65, compared to the broader market-2.000.002.004.00-0.651.59
The chart of Sortino ratio for GTG.AX, currently valued at -0.76, compared to the broader market-6.00-4.00-2.000.002.004.00-0.762.16
The chart of Omega ratio for GTG.AX, currently valued at 0.88, compared to the broader market0.501.001.502.000.881.29
The chart of Calmar ratio for GTG.AX, currently valued at -0.61, compared to the broader market0.002.004.006.00-0.612.40
The chart of Martin ratio for GTG.AX, currently valued at -0.97, compared to the broader market0.0010.0020.0030.00-0.979.79
GTG.AX
^GSPC

The current Genetic Technologies Limited Sharpe ratio is -0.65. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Genetic Technologies Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.65
2.04
GTG.AX (Genetic Technologies Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Genetic Technologies Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-99.99%
-1.51%
GTG.AX (Genetic Technologies Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Genetic Technologies Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Genetic Technologies Limited was 99.99%, occurring on Aug 8, 2024. The portfolio has not yet recovered.

The current Genetic Technologies Limited drawdown is 99.99%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.99%Dec 29, 19898876Aug 8, 2024
-66.67%Sep 30, 1988174May 31, 1989131Nov 30, 1989305
-42.86%Jun 30, 19881Jun 30, 198821Jul 29, 198822
-33.33%Apr 29, 19881Apr 29, 198822May 31, 198823

Volatility

Volatility Chart

The current Genetic Technologies Limited volatility is 0.00%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February0
3.48%
GTG.AX (Genetic Technologies Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Genetic Technologies Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Genetic Technologies Limited.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab